# Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

> **NCT00165698** · PHASE3 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** menatetranone
- **DRUG:** alfacalcidol

## Key facts

- **NCT ID:** NCT00165698
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-01
- **Final completion:** 2007-07
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2014-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165698, "Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00165698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*